In this issue
Discover the latest breakthroughs in dermatology from the 2024 Fall Clinical Dermatology Conference. This article reviews new findings on tralokinumab for atopic dermatitis (AD) and delgocitinib cream for chronic hand eczema (CHE).
Rate this content's potential impact on patient outcomes
Average rating / 5. Vote count:
No votes so far! Be the first to rate this content.
Latest articles
All articles


We’ve noticed you’re accessing
from North/South America.
from North/South America.